SCR7

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP12815CAS No. ：1533426-72-0Purity：98%

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	1533426-72-0	Cat. No.	BCP12815
Name	SCR7
Synonyms	SCR-7;SCR 7;
SMILES
Chemical Name
Formula	C18H14N4OS	M. Wt	334.39
Purity	98%	Storage	Store at 4-8°C
Description	in vitro: SCR7 does not induce DSBs directly to the genome and is Ligase IV dependent. Besides, upon incubation of oligomeric dsDNA or supercoiled plasmid DNA with increasing concentrations of SCR7, there was no evidence for DNA breaks. Accumulation of DSBs leads to cell death upon SCR7 treatment with a dose-dependent decrease in cell proliferation of MCF7, A549, and HeLa with an IC50 of 40, 34, and 44 μM, respectively, which was further confirmed by DIC imaging in MCF7. T47D, A2780, and HT1080 were also sensitive to SCR7, with an IC50 of 8.5, 120, and 10 μM, respectively. SCR7 encapsulated micelles (ES) were also characterized by small-angle neutron scattering (SANS). Encapsulated SCR7 treatment resulted in accumulation of DNA breaks within the cells, resulting in cell cycle arrest at G1 phase and activation of apoptosis. in vivo: SCR7 treatment (10 mg/kg, six doses) significantly reduced breast adenocarcinoma-induced tumor in mice. Untreated tumor animals survived only for 52 days, w